Status:
COMPLETED
Evaluation of a Personcentered Internet-based CBT Program for Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease
Lead Sponsor:
University Hospital, Linkoeping
Conditions:
Cardiovascular Disease
Psychological Distress
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate a nine-week adaptable and person-centred I-CBT program that can be directed towards stress, anxiety and depressive symptoms in persons with CVD.
Detailed Description
All patients diagnosed as CVD (i.e. diagnosis Ischemia (ICD-code I20., I25.), Heart Failure (ICD-code I50., I42.) or Arrhythmia (ICD-code I48, I49, DF016) and who received care in the last 12 months a...
Eligibility Criteria
Inclusion
- age 18 years and above
- treatment for cardiovascular disease (CVD) according to European Society of Cardiology guidelines
- stable CVD (New York Heart Association class I-III) and not having been hospitalised for CVD in in the last four weeks.
- stress (Perceived Stress Scale (PSS)-10\>13 points) and/or
- anxiety (i.e. General Anxiety Disorder Scale (GAD) ≥5 points) and/or
- depressive symptoms (Patient Health Questionnaire-9 28 (PHQ-9) \> 5 points)
Exclusion
- severe CVD (New York Heart Association classification IV) or another severe chronic life-threatening disease
- severe stress, anxiety or depression assessed as requiring acute treatment
- not being able to dedicate 3-4 hours per week to participate in the program
Key Trial Info
Start Date :
March 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT04726722
Start Date
March 13 2023
End Date
June 30 2025
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peter Johansson
Norrköping, Linköpings Universitet, Sweden, 601 74